BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34258102)

  • 1. Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
    Dillon LW; Ghannam J; Nosiri C; Gui G; Goswami M; Calvo KR; Lindblad KE; Oetjen KA; Wilkerson MD; Soltis AR; Sukumar G; Dalgard CL; Thompson J; Valdez J; DeStefano CB; Lai C; Sciambi A; Durruthy-Durruthy R; Llanso A; Gulati S; Wang S; Ooi A; Dagur PK; McCoy JP; Burr P; Li Y; Hourigan CS
    Blood Cancer Discov; 2021 Jul; 2(4):319-325. PubMed ID: 34258102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease.
    Martignoles JA; Delhommeau F; Hirsch P
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.
    Hasserjian RP; Steensma DP; Graubert TA; Ebert BL
    Blood; 2020 May; 135(20):1729-1738. PubMed ID: 32232484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and risk of acute myeloid leukemia.
    Young AL; Tong RS; Birmann BM; Druley TE
    Haematologica; 2019 Dec; 104(12):2410-2417. PubMed ID: 31004019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis.
    Niemöller C; Renz N; Bleul S; Blagitko-Dorfs N; Greil C; Yoshida K; Pfeifer D; Follo M; Duyster J; Claus R; Ogawa S; Lübbert M; Becker H
    Leuk Res; 2016 Aug; 47():41-6. PubMed ID: 27244256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
    Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
    Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis.
    El Hussein S; Loghavi S
    Clin Lab Med; 2023 Sep; 43(3):411-426. PubMed ID: 37481320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM
    N Engl J Med; 2018 Mar; 378(13):1189-1199. PubMed ID: 29601269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.
    Robinson TM; Bowman RL; Persaud S; Liu Y; Neigenfind R; Gao Q; Zhang J; Sun X; Miles LA; Cai SF; Sciambi A; Llanso A; Famulare C; Goldberg A; Dogan A; Roshal M; Levine RL; Xiao W
    Sci Adv; 2023 Sep; 9(38):eadg0488. PubMed ID: 37729414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments.
    Simonsen AT; Meggendorfer M; Hansen MH; Nederby L; Koch S; Hansen M; Rosenberg CA; Kern W; Nyvold CG; Aggerholm A; Haferlach T; Ommen HB
    Exp Hematol; 2022 Mar; 107():51-59. PubMed ID: 35122908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
    Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
    Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.
    Grimm J; Bill M; Jentzsch M; Beinicke S; Häntschel J; Goldmann K; Schulz J; Cross M; Franke GN; Behre G; Vucinic V; Pönisch W; Lange T; Niederwieser D; Schwind S
    Bone Marrow Transplant; 2019 Aug; 54(8):1189-1197. PubMed ID: 30504903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.
    Fernandez C; Santos-Silva MC; López A; Matarraz S; Jara-Acevedo M; Ciudad J; Gutierrez ML; Sánchez ML; Salvador-Osuna C; Berruezo MJ; Díaz-Arias JÁ; Palomo-Hernández AM; Colado E; González N; Gallardo D; Asensio A; García-Sánchez R; Saldaña R; Cerveró C; Carboné-Bañeres A; Gutierrez O; Orfao A
    Leukemia; 2013 Nov; 27(11):2149-56. PubMed ID: 23579575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.
    Chaudry SF; Chevassut TJ
    Biomed Res Int; 2017; 2017():5473197. PubMed ID: 28286768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
    Venanzi A; Marra A; Schiavoni G; Milner SG; Limongello R; Santi A; Pettirossi V; Ultimo S; Tasselli L; Pucciarini A; Falini L; Sciabolacci S; Martelli MP; Sportoletti P; Ascani S; Falini B; Tiacci E
    Blood Cancer Discov; 2021 May; 2(3):216-225. PubMed ID: 34164626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.